☰

Michael P. Clark - Publications

Affiliations: 
2001 Indiana University, Bloomington, Bloomington, IN, United States 
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Williams DR, Clark MP. ChemInform Abstract: The Macrocyclic Domain of Phorboxazole A. A Stereoselective Synthesis of the C1-C32 Macrolactone. Cheminform. 30: no-no. DOI: 10.1002/chin.199925219  0.447
2010 Williams DR, Clark MP, Berliner MA. ChemInform Abstract: Synthetic Studies Toward Phorboxazole A. Stereoselective Synthesis of the C3-C19 and C20-C32 Subunits. Cheminform. 30: no-no. DOI: 10.1002/chin.199925218  0.733
2010 WILLIAMS DR, BROOKS DA, MEYER KG, CLARK MP. ChemInform Abstract: Asymmetric Allylation. An Effective Strategy for the Convergent Synthesis of Highly Functionalized Homoallylic Alcohols Cheminform. 30: no-no. DOI: 10.1002/chin.199901261  0.764
2007 Clark MP, George KM, Bookland RG, Chen J, Laughlin SK, Thakur KD, Lee W, Davis JR, Cabrera EJ, Brugel TA, VanRens JC, Laufersweiler MJ, Maier JA, Sabat MP, Golebiowski A, et al. Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3). Bioorganic & Medicinal Chemistry Letters. 17: 1250-3. PMID 17189692 DOI: 10.1016/j.bmcl.2006.12.018  0.685
2006 Sabat M, Vanrens JC, Clark MP, Brugel TA, Maier J, Bookland RG, Laufersweiler MJ, Laughlin SK, Golebiowski A, De B, Hsieh LC, Walter RL, Mekel MJ, Janusz MJ. The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-alpha production. Bioorganic & Medicinal Chemistry Letters. 16: 4360-5. PMID 16750367 DOI: 10.1016/j.bmcl.2006.05.050  0.765
2006 Brugel TA, Maier JA, Clark MP, Sabat M, Golebiowski A, Bookland RG, Laufersweiler MJ, Laughlin SK, Vanrens JC, De B, Hsieh LC, Mekel MJ, Janusz MJ. Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1. Bioorganic & Medicinal Chemistry Letters. 16: 3510-3. PMID 16632356 DOI: 10.1016/j.bmcl.2006.03.095  0.744
2006 Maier JA, Brugel TA, Clark MP, Sabat M, Golebiowski A, Bookland RG, Laufersweiler MJ, Laughlin SK, Vanrens JC, De B, Hsieh LC, Brown KK, Juergens K, Walter RL, Janusz MJ. Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2. Bioorganic & Medicinal Chemistry Letters. 16: 3514-8. PMID 16632350 DOI: 10.1016/j.bmcl.2006.03.096  0.746
2006 Brugel TA, Hudlicky T, Clark MP, Golebiowski A, Sabat M, Endoma MAA, Bui V, Adams D, Laufersweiler MJ, Maier JA, Bookland RG, De B. Convergent synthesis of 2,3-bisarylpyrazolones through cyclization of bisacylated pyrazolidines and hydrazines Tetrahedron Letters. 47: 3195-3198. DOI: 10.1016/J.Tetlet.2006.03.063  0.731
2006 Brugel TA, Maier JA, Clark MP, Sabat M, Golebiowski A, Bookland RG, Laufersweiler MJ, Laughlin SK, VanRens JC, De B, Hsieh LC, Mekel MJ, Janusz MJ. Corrigendum to "Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1" [Bioorg. Med. Chem. Lett. 16 (2006) 3510-3513] (DOI:10.1016/j.bmcl.2006.03.095) Bioorganic and Medicinal Chemistry Letters. 16: 4700. DOI: 10.1016/j.bmcl.2006.06.013  0.736
2005 Williams DR, Berliner MA, Stroup BW, Nag PP, Clark MP. Samarium Barbier reactions of alpha-iodomethyloxazoles and thiazoles with aliphatic aldehydes. Organic Letters. 7: 4099-102. PMID 16146361 DOI: 10.1021/Ol051345V  0.782
2005 Laughlin SK, Clark MP, Djung JF, Golebiowski A, Brugel TA, Sabat M, Bookland RG, Laufersweiler MJ, VanRens JC, Townes JA, De B, Hsieh LC, Xu SC, Walter RL, Mekel MJ, et al. The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production. Bioorganic & Medicinal Chemistry Letters. 15: 2399-403. PMID 15837333 DOI: 10.1016/j.bmcl.2005.02.066  0.742
2005 Golebiowski A, Townes JA, Laufersweiler MJ, Brugel TA, Clark MP, Clark CM, Djung JF, Laughlin SK, Sabat MP, Bookland RG, VanRens JC, De B, Hsieh LC, Janusz MJ, Walter RL, et al. The development of monocyclic pyrazolone based cytokine synthesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 15: 2285-9. PMID 15837310 DOI: 10.1016/j.bmcl.2005.03.007  0.743
2004 Townes JA, Golebiowski A, Clark MP, Laufersweiler MJ, Brugel TA, Sabat M, Bookland RG, Laughlin SK, VanRens JC, De B, Hsieh LC, Xu SC, Janusz MJ, Walter RL. The development of new bicyclic pyrazole-based cytokine synthesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 14: 4945-8. PMID 15341957 DOI: 10.1016/j.bmcl.2004.07.024  0.748
2004 Williams DR, Kiryanov AA, Emde U, Clark MP, Berliner MA, Reeves JT. Studies of stereocontrolled allylation reactions for the total synthesis of phorboxazole A. Proceedings of the National Academy of Sciences of the United States of America. 101: 12058-63. PMID 15277662 DOI: 10.1073/Pnas.0402477101  0.735
2004 Laufersweiler MJ, Brugel TA, Clark MP, Golebiowski A, Bookland RG, Laughlin SK, Sabat MP, Townes JA, VanRens JC, De B, Hsieh LC, Heitmeyer SA, Juergens K, Brown KK, Mekel MJ, et al. The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones. Bioorganic & Medicinal Chemistry Letters. 14: 4267-72. PMID 15261284 DOI: 10.1016/j.bmcl.2004.06.001  0.739
2004 Clark MP, Laughlin SK, Laufersweiler MJ, Bookland RG, Brugel TA, Golebiowski A, Sabat MP, Townes JA, VanRens JC, Djung JF, Natchus MG, De B, Hsieh LC, Xu SC, Walter RL, et al. Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-alpha production. Journal of Medicinal Chemistry. 47: 2724-7. PMID 15139749 DOI: 10.1021/jm049968m  0.738
2003 Tullis JS, VanRens JC, Natchus MG, Clark MP, De B, Hsieh LC, Janusz MJ. The development of new triazole based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production. Bioorganic & Medicinal Chemistry Letters. 13: 1665-8. PMID 12729637 DOI: 10.1016/S0960-894X(03)00238-5  0.356
2003 Williams DR, Kiryanov AA, Emde U, Clark MP, Berliner MA, Reeves JT. Total synthesis of phorboxazole A. Angewandte Chemie (International Ed. in English). 42: 1258-62. PMID 12645057 DOI: 10.1002/anie.200390322  0.714
2001 Williams DR, Patnaik S, Clark MP. Total synthesis of cystothiazoles A and C. The Journal of Organic Chemistry. 66: 8463-9. PMID 11735526 DOI: 10.1021/Jo0106905  0.681
2000 Williams DR, Clark MP, Emde U, Berliner MA. Synthetic studies toward phorboxazole A. stereoselective synthesis of the C(28)-C(46) side chain fragment. Organic Letters. 2: 3023-6. PMID 10986098 DOI: 10.1021/Ol0063656  0.773
1999 Williams DR, Clark MP. The macrocyclic domain of phorboxazole A. A stereoselective synthesis of the C1-C32 macrolactone Tetrahedron Letters. 40: 2291-2294. DOI: 10.1016/S0040-4039(99)00210-5  0.456
1999 Williams DR, Clark MP, Berliner MA. Synthetic studies toward Phorboxazole A. Stereoselective synthesis of the C3-C19 and C20-C32 subunits Tetrahedron Letters. 40: 2287-2290. DOI: 10.1016/S0040-4039(99)00209-9  0.764
1998 Williams DR, Clark MP. Synthesis of atovaquone Tetrahedron Letters. 39: 7629-7632. DOI: 10.1016/S0040-4039(98)01691-8  0.366
1998 Williams DR, Clark MP. Synthesis of atovaquone Tetrahedron Letters. 39: 7629-7632. DOI: 10.1016/S0040-4039(98)01691-8  0.458
1998 Williams DR, Brooks DA, Meyer KG, Clark MP. Asymmetric allylation. An effective strategy for the convergent synthesis of highly functionalized homoallylic alcohols Tetrahedron Letters. 39: 7251-7254. DOI: 10.1016/S0040-4039(98)01557-3  0.765
Show low-probability matches.